Evidence map›Paper›PMID 34235186›Full record

ArticleFrontiers in cardiovascular medicine2021

Patient Characteristics and Preferences Regarding Anticoagulant Treatment in Venous Thromboembolic Disease.

Damien Lanéelle, Charles Le Brun, Chadi Mauger, Jérôme Guillaumat, Estelle Le Pabic, Loukman Omarjee, Guillaume Mahé, SFMV VTE Study Group

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Damien LanéelleCentre Hospitalier Universitaire Caen Normandie, Service de Médecine Vasculaire, Caen, France.
Charles Le BrunCentre Hospitalier Universitaire de Rennes, Department of Vascular Medicine, Rennes, France.
Chadi MaugerCentre Hospitalier Universitaire de Rennes, Department of Vascular Medicine, Rennes, France.
Jérôme GuillaumatCentre Hospitalier Universitaire Caen Normandie, Service de Médecine Vasculaire, Caen, France.
Estelle Le PabicCentre Hospitalier Universitaire de Rennes, Department of Vascular Medicine, Rennes, France.
Loukman OmarjeeCentre Hospitalier Universitaire de Rennes, Department of Vascular Medicine, Rennes, France.
Guillaume MahéCentre Hospitalier Universitaire de Rennes, Department of Vascular Medicine, Rennes, France.
SFMV VTE Study Group
Centre Hospitalier Universitaire de Rennes · FRCentre Hospitalier Universitaire de Caen · FRUniversité de Caen Normandie · FRUniversité de Rennes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticoagulation/administration and dosinganticoagulation managementpatient concernpatient preference (MeSH)venous thromboembolism disease (VTE disease)

Identifiers

PMID34235186
PMCPMC8255622
OpenAlexW3176186933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.